TY - JOUR
T1 - Rapid and Systematic Exploration of Chemical Space Relevant to Artemisinins
T2 - Anti-malarial Activities of Skeletally Diversified Tetracyclic Peroxides and 6-Aza-artemisinins
AU - Bonepally, Karunakar Reddy
AU - Takahashi, Norihito
AU - Matsuoka, Naoya
AU - Koi, Hikari
AU - Mizoguchi, Haruki
AU - Hiruma, Takahisa
AU - Ochiai, Kyohei
AU - Suzuki, Shun
AU - Yamagishi, Yutaka
AU - Oikawa, Hideaki
AU - Ishiyama, Aki
AU - Hokari, Rei
AU - Iwatsuki, Masato
AU - Otoguro, Kazuhiko
AU - Mura, Satoshi
AU - Kato, Nobutaka
AU - Oguri, Hiroki
N1 - Funding Information:
The authors thank Drs. Timothy N. C. Wells, Jeremy Burrows, and Didier Leroy of Medicines for Malaria Venture (MMV) as well as Prof. Stuart L. Schreiber (Broad Institute and Harvard Univ.) for their invaluable advice and continuous support. The authors thank Mr. Takashi Matsumoto (Rigaku) and Mr. Ryo Watanabe (Hokkaido Univ.) for X-ray analysis. This work was supported in part by the GHIT fund HTLP RFP (2014-001), JSPS KAKENHI (grant numbers JP23310156, JP26102702, JP16H01135, and JP18H04388), the Naito Foundation, and the Uehara Memorial Foundation. This work was inspired by the international and interdisciplinary environments of the JSPS Asian CORE Program, “Asian Chemical Biology Initiative”, and JSPS A3 Foresight Program.
Publisher Copyright:
Copyright © 2020 American Chemical Society.
PY - 2020/8/7
Y1 - 2020/8/7
N2 - To achieve both structural changes and rapid synthesis of the tetracyclic scaffold relevant to artemisinins, we explored two kinds of de novo synthetic approaches that generate both skeletally diversified tetracyclic peroxides and 6-aza-artemisinins. The anti-malarial activities of the tetracyclic peroxides with distinct skeletal arrays, however, were moderate and far inferior to artemisinins. Given the privileged scaffold of artemisinins, we next envisioned element implantation at the C6 position with a nitrogen without the trimmings of substituents and functional groups. This molecular design allowed the deep-seated structural modification of the hitherto unexplored cyclohexane moiety (C-ring) while keeping the three-dimensional structure of artemisinins. Notably, this approach induced dramatic changes of retrosynthetic transforms that allow an expeditious catalytic asymmetric synthesis with generation of substitutional variations at three sites (N6, C9, and C3) of the 6-aza-artemisinins. These de novo synthetic approaches led to the lead discovery with substantial intensification of the in vivo activities, which undermine the prevailing notion that the C-ring of artemisinins appears to be merely a structural unit but to be a functional area as the anti-malarial pharmacophore. Furthermore, we unexpectedly found that racemic 6-aza-artemisinin (33) exerted exceedingly potent in vivo efficacies superior to the chiral one and the first-line drug, artesunate.
AB - To achieve both structural changes and rapid synthesis of the tetracyclic scaffold relevant to artemisinins, we explored two kinds of de novo synthetic approaches that generate both skeletally diversified tetracyclic peroxides and 6-aza-artemisinins. The anti-malarial activities of the tetracyclic peroxides with distinct skeletal arrays, however, were moderate and far inferior to artemisinins. Given the privileged scaffold of artemisinins, we next envisioned element implantation at the C6 position with a nitrogen without the trimmings of substituents and functional groups. This molecular design allowed the deep-seated structural modification of the hitherto unexplored cyclohexane moiety (C-ring) while keeping the three-dimensional structure of artemisinins. Notably, this approach induced dramatic changes of retrosynthetic transforms that allow an expeditious catalytic asymmetric synthesis with generation of substitutional variations at three sites (N6, C9, and C3) of the 6-aza-artemisinins. These de novo synthetic approaches led to the lead discovery with substantial intensification of the in vivo activities, which undermine the prevailing notion that the C-ring of artemisinins appears to be merely a structural unit but to be a functional area as the anti-malarial pharmacophore. Furthermore, we unexpectedly found that racemic 6-aza-artemisinin (33) exerted exceedingly potent in vivo efficacies superior to the chiral one and the first-line drug, artesunate.
UR - http://www.scopus.com/inward/record.url?scp=85090014765&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85090014765&partnerID=8YFLogxK
U2 - 10.1021/acs.joc.0c01017
DO - 10.1021/acs.joc.0c01017
M3 - Article
AN - SCOPUS:85090014765
SN - 0022-3263
VL - 85
SP - 9694
EP - 9712
JO - Journal of Organic Chemistry
JF - Journal of Organic Chemistry
IS - 15
ER -